Literature DB >> 7811534

HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals.

N Berry1, K Ariyoshi, O Jobe, P T Ngum, T Corrah, A Wilkins, H Whittle, R Tedder.   

Abstract

The efficiency of detection of 2 sets of primer pairs from putatively conserved regions of the human immunodeficiency virus type 2 (HIV-2) genome were assessed in 86 seropositive individuals from The Gambia by nested polymerase chain reaction (PCR). HIV-2 long terminal repeat (LTR) target sequences were detected in DNA extracted from peripheral blood mononuclear cells (PBMCs) in 84 of 86 (97%) individuals whereas HIV-2 integrase (pol) gene sequences were detected in 39 of 41 (95%) individuals. The use of LTR target sequences and recombinant Pfu DNA polymerase, rather than Taq polymerase, in a modified secondary amplification reaction mediated the incorporation of 35S-labeled nucleotides in a quantitative radiometric assay. This sensitive assay was used to quantify HIV-2 proviral DNA in clinical samples and compared well with estimations by limiting end-point dilution of target molecules. A linear response between counts and the number of copies amplified from serial dilutions of pROD10 plasmid DNA (3-2000 copies) yielded a standard curve to allow extrapolation to clinical data. Increased levels of HIV-2 proviral DNA, expressed as copies per 10(5) CD4-positive lymphocytes, were associated with declining CD4 count in 63 adult patients (Spearman rank correlation, r = -0.71, n = 63, p < 0.001) and with the occurrence of HIV-related clinical disease. Kruskall-Wallis analysis of variance analysis showed the mean proviral copy number (log10) to be significantly different between groups (p < 0.001) where CD4 counts were grouped as < 200/mm3 (3.4 +/- 1.05 copies), 200-500/mm3 (2.84 +/- 0.93 copies), and > 500/mm3 (1.88 +/- 0.43 copies).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Keywords:  Diseases; Examinations And Diagnoses; Hematologic Tests; Hiv Infections; Laboratory Examinations And Diagnoses; Laboratory Procedures; Research Report; Viral Diseases

Mesh:

Substances:

Year:  1994        PMID: 7811534     DOI: 10.1089/aid.1994.10.1031

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  19 in total

1.  Highly sensitive method for amplification of human immunodeficiency virus type 2 DNA.

Authors:  F Damond; I Loussert-Ajaka; C Apetrei; D Descamps; S Souquière; A Leprêtre; S Matheron; F Brun-Vézinet; F Simon
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

Review 2.  Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.

Authors:  M Clementi; S Menzo; P Bagnarelli; A Valenza; S Paolucci; R Sampaolesi; A Manzin; P E Varaldo
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo.

Authors:  S J Popper; A D Sarr; A Guèye-Ndiaye; S Mboup; M E Essex; P J Kanki
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Improving HIV-2 detection by a combination of serological and nucleic acid amplification test assays.

Authors:  Anna Rita Ciccaglione; Michela Miceli; Giulio Pisani; Roberto Bruni; Paola Iudicone; Angela Costantino; Michele Equestre; Elena Tritarelli; Cinzia Marcantonio; Paola Tataseo; Maria Cristina Marazzi; Susanna Ceffa; Giovanna Paturzo; Anna Maria Doro Altan; Massimo Magnano San Lio; Sandro Mancinelli; Massimo Ciccozzi; Alessandra Lo Presti; Giovanni Rezza; Leonardo Palombi
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

5.  Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR.

Authors:  F Damond; D Descamps; I Farfara; J N Telles; S Puyeo; P Campa; A Leprêtre; S Matheron; F Brun-Vezinet; F Simon
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Proviral load and immune function in blood and lymph node during HIV-1 and HIV-2 infection.

Authors:  O Jobe; K Ariyoshi; A Marchant; S Sabally; T Corrah; N Berry; S Jaffar; H Whittle
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

7.  Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype.

Authors:  N C Grassly; Z Xiang; K Ariyoshi; P Aaby; H Jensen; M Schim van der Loeff; F Dias; H Whittle; J Breuer
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

8.  Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay.

Authors:  P Gomes; N C Taveira; J M Pereira; F Antunes; M O Ferreira; M H Lourenço
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

9.  Differences in proviral DNA load between HIV-1-infected and HIV-2-infected patients.

Authors:  Geoffrey S Gottlieb; Stephen E Hawes; Nancy B Kiviat; Papa Salif Sow
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

10.  Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease.

Authors:  Rita Cavaleiro; António P Baptista; Rui S Soares; Rita Tendeiro; Russell B Foxall; Perpétua Gomes; Rui M M Victorino; Ana E Sousa
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.